Fredag 20 Juni | 07:27:21 Europe / Stockholm

Kalender

Est. tid*
2026-02-03 08:00 Bokslutskommuniké 2025
2025-10-21 07:00 Kvartalsrapport 2025-Q3
2025-07-22 07:00 Kvartalsrapport 2025-Q2
2025-04-29 - Kvartalsrapport 2025-Q1
2025-03-13 - X-dag ordinarie utdelning EMBLA 0.00 DKK
2025-03-12 - Årsstämma
2025-02-05 - Bokslutskommuniké 2024
2024-10-22 - Kvartalsrapport 2024-Q3
2024-07-23 - Kvartalsrapport 2024-Q2
2024-04-23 - Kvartalsrapport 2024-Q1
2024-03-13 - Årsstämma
2024-03-13 - X-dag ordinarie utdelning EMBLA 0.00 DKK
2024-03-12 - Årsstämma
2024-01-30 - Bokslutskommuniké 2023
2023-10-24 - Kvartalsrapport 2023-Q3
2023-07-25 - Kvartalsrapport 2023-Q2
2023-04-25 - Kvartalsrapport 2023-Q1
2023-03-13 - X-dag ordinarie utdelning EMBLA 0.00 DKK
2023-03-10 - Årsstämma
2023-01-31 - Bokslutskommuniké 2022
2022-10-25 - Kvartalsrapport 2022-Q3
2022-07-21 - Kvartalsrapport 2022-Q2
2022-04-26 - Kvartalsrapport 2022-Q1
2022-03-09 - X-dag ordinarie utdelning EMBLA 0.00 DKK
2022-03-08 - Årsstämma
2022-02-01 - Bokslutskommuniké 2021
2021-10-26 - Kvartalsrapport 2021-Q3
2021-07-22 - Kvartalsrapport 2021-Q2
2021-04-27 - Kvartalsrapport 2021-Q1
2021-03-09 - X-dag ordinarie utdelning EMBLA 0.00 DKK
2021-03-08 - Årsstämma
2021-02-02 - Bokslutskommuniké 2020
2020-10-27 - Kvartalsrapport 2020-Q3
2020-07-23 - Kvartalsrapport 2020-Q2
2020-04-30 - Kvartalsrapport 2020-Q1
2020-03-13 - X-dag ordinarie utdelning EMBLA 0.15 DKK
2020-03-12 - Årsstämma
2020-02-04 - Bokslutskommuniké 2019
2019-10-22 - Kvartalsrapport 2019-Q3
2019-07-25 - Kvartalsrapport 2019-Q2
2019-04-30 - Kvartalsrapport 2019-Q1
2019-03-08 - X-dag ordinarie utdelning EMBLA 0.14 DKK
2019-03-07 - Årsstämma
2019-02-05 - Bokslutskommuniké 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-07-25 - Kvartalsrapport 2018-Q2
2018-04-25 - Kvartalsrapport 2018-Q1
2018-03-09 - X-dag ordinarie utdelning EMBLA 0.13 DKK
2018-03-08 - Årsstämma
2018-02-05 - Bokslutskommuniké 2017
2017-10-24 - Kvartalsrapport 2017-Q3
2017-07-25 - Kvartalsrapport 2017-Q2
2017-04-27 - Kvartalsrapport 2017-Q1
2017-03-10 - X-dag ordinarie utdelning EMBLA 0.12 DKK
2016-03-11 - X-dag ordinarie utdelning EMBLA 0.12 DKK
2016-03-10 - Årsstämma
2016-02-02 - Bokslutskommuniké 2015
2015-10-22 - Kvartalsrapport 2015-Q3
2015-07-23 - Kvartalsrapport 2015-Q2
2015-04-29 - Kvartalsrapport 2015-Q1
2015-03-12 - Årsstämma
2015-02-05 - Bokslutskommuniké 2014
2014-10-24 - Analytiker möte 2014
2014-10-23 - Kvartalsrapport 2014-Q3
2014-07-25 - Analytiker möte 2014
2014-07-24 - Kvartalsrapport 2014-Q2
2014-04-30 - Analytiker möte 2014
2014-04-29 - Kvartalsrapport 2014-Q1
2014-03-14 - Årsstämma
2014-02-05 - Bokslutskommuniké 2013
2013-10-24 - Analytiker möte 2013
2013-10-23 - Kvartalsrapport 2013-Q3
2013-07-24 - Kvartalsrapport 2013-Q2
2013-04-24 - Kvartalsrapport 2013-Q1
2013-03-15 - Årsstämma
2013-02-06 - Bokslutskommuniké 2012
2012-11-28 - Kapitalmarknadsdag 2012
2012-11-27 - Kapitalmarknadsdag 2012
2012-10-24 - Analytiker möte 2012
2012-10-23 - Kvartalsrapport 2012-Q3
2012-07-25 - Kvartalsrapport 2012-Q2
2012-04-24 - Kvartalsrapport 2012-Q1
2012-03-16 - Årsstämma
2012-02-08 - Bokslutskommuniké 2011
2011-10-27 - Kvartalsrapport 2011-Q3
2011-07-28 - Kvartalsrapport 2011-Q2
2011-03-04 - Årsstämma

Beskrivning

LandIsland
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Embla Medical är ett isländskt bolag verksamma inom hälsa och sjukvård. Idag innehas affärsinriktning mot utvecklandet av benproteser, artros samt relaterad skadehantering. Produkterna är anpassade för olika åldrar och förutsättningar beroende på patientens svårighetsgrad. Verksamheten är etablerad globalt med störst marknad inom Europa följt av Nordamerika. Embla Medical grundades under 1971 och har sitt huvudkontor i Reykjavik.
2025-06-18 11:37:48

Company honored by Forbes Magazine for Championing Accessibility and by Iceland's President for Excellence in Global Exports

Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, is being internationally recognized for its pioneering role in enhancing peoples' mobility and its business leadership, the company announced today.

Forbes Magazine has named Embla Medical to its first-ever global Accessibility 100 list, recognizing the company's history of innovative prosthetics, neuro orthotics and bracing solutions, and high-quality patient care services. The prestigious list recognizes, for the first time, innovators in the field of accessibility for people with disabilities.

Embla Medical is home to a number of leading mobility brands, including Össur, a leading global provider of prosthetics and bracing and supports solutions; Fior & Gentz, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels. 

Since its founding in 1971, Embla Medical has secured more than 2,100 patents and numerous award-winning designs and is renowned for advancing the Orthotic & Prosthetic (O&P) industry. The company also operates ForMotion patient care clinics, which provide innovative solutions, expert guidance, and personalized care and support to patients in countries around the globe.

The Forbes list was curated through interviews with more than 400 accessibility leaders across 15+ countries. Organizations were selected based on impact, innovation, and potential to drive systemic change across industries.  In addition to Embla Medical, other companies on the list include global tech giants Google, Apple, Microsoft, Meta, and Sony, and apparel brand Nike, with whom Össur partnered for the Nike Sole on its Össur Cheetah® sports blade.

"Accessibility is a fascinating space that has never been captured like this before," said Alan Schwarz, Forbes Assistant Managing Editor who spearheaded the project. "There are lone innovators, juggernaut tech companies, startups. They are revolutionizing how people get around, learn, communicate, work, play sports, travel, and so much more. Their impact on people's lives is monumental - and will only be getting more so soon."

"We are honored to have received this recognition as a purpose-driven company that is passionately committed to improving the quality of life for people experiencing chronic mobility challenges," said Sveinn Sölvason, Embla Medical's President and CEO. "From designing award-winning mobility solutions to operating our network of patient care clinics, we remain singularly focused on providing innovative mobility solutions that help more people live a Life Without Limitations."

According to Sölvason, Embla Medical has also received the President of Iceland`s Export Award for 2025, recognizing the company's success as an international business.

"This recognition speaks to the dedication, and global impact of our entire team, and accepting the award from President Halla Tómasdóttir was a very meaningful moment," Sölvason said, noting that the first time the company received this honor was in 1992, as a small Icelandic company employing around 20 people at that time.

"Today," he continued, "we have more than 4,000 employees, operating in 36 countries, and countless individuals rely on our solutions every day. What hasn`t changed over the years is our purpose: to improve the lives of people facing mobility challenges. Although we have grown globally, our roots remain in Iceland, shaped by a culture of resilience, innovation, and ambition. This award is not just a celebration of how far we've come - it's also a reminder of the importance of continued investment in new innovation and the conditions that allow global businesses to thrive."